Comparing the American and European diagnostic guidelines for cystic fibrosis: Same disease, different language?

Thorax

Volumn 67, Issue 7, 2012, Pages 618-624

  Ooi, Chee Y ^a,b,c   Dupuis, Annie ^c,d   Ellis, Lynda ^c   Jarvi, Keith ^e   Martin, Sheelagh ^c   Gonska, Tanja ^b,c   Dorfman, Ruslan ^b   Kortan, Paul ^f   Solomon, Melinda ^b,c   Tullis, Elizabeth ^f,g   Durie, Peter R ^b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; AGED; ARTICLE; AZOOSPERMIA; CFTR GENE; CHILD; CHRONIC RECURRENT PANCREATITIS; CHRONIC SINOPULMONARY DISEASE; COMPARATIVE STUDY; CYSTIC FIBROSIS; EUROPE; FEMALE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; KAPPA STATISTICS; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PANCREATITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SWEAT TEST; UNITED STATES;

EID: 84862763252     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2011-201454     Document Type: Article

References (32)

1. Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998;339:645-52.
2. Ooi CY, Dorfman R, Cipolli M, et al. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology 2011;140:153-61.
3. Bishop MD, Freedman SD, Zielenski J, et al. The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis. Hum Genet 2005;118:372-81.
4. Girodon E, Cazeneuve C, Lebargy F, et al. CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet 1997;5:149-55.
5. Jarvi K, Zielenski J, Wilschanski M, et al. Cystic fibrosis transmembrane regulator and obstructive azoospermia. Lancet 1995;345:1578.
6. Wilschanski M, Dupuis A, Ellis L, et al. Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials. Am J Resp Crit Care Med 2006;174:787-94.
7. Farrell PM, Rosenstein BJ, White TB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation Consensus Report. J Pediatr 2008;153:S4-14.
8. De Boeck K, Wilschanski M, Castellani C, et al. Cystic fibrosis: terminology and diagnostic algorithms. Thorax 2006;61:627-35.
9. Watson MS, Cutting GR, Desnick RJ, et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 2004;6:387-91.
10. Goubau C, Wilschanski M, Skalická V, et al. Phenotypic characterization of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis. Thorax 2009;64:683-91.
11. Gonska T, Choi P, Stephenson A, et al. Role of cystic fibrosis transmembrane conductance regulator (CFTR) in patients with chronic sinopulmonary disease. Chest. Published Online First: 15 Mar 2012. doi:10.1378/chest.11-2543.
12. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959;23:545-9.
13. Hammond KB, Turcios NL, Gibson LE. Clinical evaluation of the Macroduct sweat collection system and conductivity analyzer in the diagnosis of cystic fibrosis. J Pediatr 1994;124:255-60.
14. Knowles MR, Paradiso AM, Boucher RC. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther 1995;6:445-55.
15. Zielenski J, Aznarez I, Onay T, et al. CFTR mutation detection by multiplex heteroduplex (mHET) analysis on MDE gel. Methods Mol Med 2002;70:3-19.
16. Ferec C, Casals T, Chuzhanova N, et al. Gross genomic rearrangements involving Deletions in the CFTR gene: characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes and meta-analysis of the underlying mechanisms. Eur J Hum Genet 2006;14:567-76.
17. Audrezet MP, Chen JM, Raguenes O, et al. Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms. Hum Mutat 2004;23:343-57.
18. Castellani C, Cuppens H, Macek M Jr, et al. Consensus on the use and clinical interpretation of cystic fibrosis mutation analysis in clinical practice. J Cystic Fibrosis 2008;7:179-96.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
20. Mishra A, Greaves R, Smith K, et al. Diagnosis of cystic fibrosis by sweat testing: age-specific reference intervals. J Pediatr 2008;153:758-63.
21. Bienvenu T, Sermet-Gaudelus I, Burgel PR, et al. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2010;181:1078-84.
22. Clinical and Functional Translation of CFTR. Baltimore: John Hopkins University. http://www.cftr2.com (accessed 5 Apr 2012).
23. Cantin AM, Hanrahan JW, Bilodeau, et al. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am J Respir Crit Care Med 2006;173:1139-44.
24. Middleton PG, House HH. Measurement of airway ion transport assists the diagnosis of cystic fibrosis. Pediatr Pulmonol 2010;45:789-95.
25. Veeze HJ, Sinaasappel M, Bijman J, et al. Ion transport abnormalities in rectal suction biopsies from children with cystic fibrosis. Gastroenterology 1991;101:398-403.
26. Bombieri C, Claustres M, De Boeck K, et al. Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros 2011;10(Suppl 2):S86-102.
27. Gilljam M, Moltyaner Y, Downey GP, et al. Airway inflammation and infection in congenital bilateral absence of the vas deferens. Am J Respir Crit Care Med 2004;169:174-9.
28. Gilljam K, Ellis L, Corey M, et al. Clinical manifestations of cystic fibrosis among patients diagnosed in adulthood. Chest 2004;126:1215-24.
29. Borowitz D, Parad R, Sharp JK, et al. Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. J Pediatr 2009;155:S106-16.
30. Rose JB, Ellis J, John B, et al. Does the Macroduct® collection system reliably define sweat chloride concentration in subjects with intermediate results? Clin Biochem 2009;42:1260-4.
31. Hammond KB, Nelson MS, Turcois L, et al. Clinical evaluation of the Macroduct sweat collection system and conductivity analyzer in the diagnosis of cystic fibrosis. J Pediatrics 1994;124:255-60.
32. Clinical Laboratory Standards Institute formerly National Committee for Clinical Laboratory Standards. Sweat Testing: Sample Collection and Quantitative Analysis: Approved Guideline: National Committee for Clinical Laboratory Standards. Wayne, PA: Clinical Laboratory Standards Institute, 2000. NCCLS Document C34-A2.